Cwc Advisors, Llc. Ligand Pharmaceuticals Inc Transaction History
Cwc Advisors, Llc.
- $204 Billion
- Q3 2025
A detailed history of Cwc Advisors, Llc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cwc Advisors, Llc. holds 3,538 shares of LGND stock, worth $652,725. This represents 0.31% of its overall portfolio holdings.
Number of Shares
3,538
Previous 3,518
0.57%
Holding current value
$652,725
Previous $400 Million
56.71%
% of portfolio
0.31%
Previous 0.21%
Shares
5 transactions
Others Institutions Holding LGND
# of Institutions
290Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$530 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$385 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$196 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$171 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$138 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.11B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...